Upcoming IPOs This Week (Feb 9–13, 2026)

The primary market remains active with several upcoming IPOs scheduled this week, offering investors opportunities across financial services, analytics, and technology segments. Mainboard offerings from Aye Finance and Fractal Analytics open early in the week, while SME player Marushika Technology joins later, giving investors multiple subscription windows to evaluate.

Aye Finance IPO Details

Aye Finance’s ₹1,010 crore IPO is a combination of a fresh issue worth ₹710 crore and an offer for sale aggregating ₹300 crore. The IPO opens for subscription on February 9 and closes on February 11, with allotment expected on February 12. The company is scheduled to list on both BSE and NSE on February 16.

The price band has been fixed at ₹122–₹129 per share, and the minimum retail investment stands at ₹14,964 for one lot of 116 shares.

Fractal Analytics IPO Details

Fractal Analytics plans to raise ₹2,833.90 crore through a mix of fresh issue and offer for sale. The IPO also opens on February 9 and closes on February 11, with listing expected on February 16 on BSE and NSE.

The issue price band is ₹857–₹900 per share, and the minimum retail investment amount comes to ₹14,400 for one lot of 16 shares.

Marushika Technology IPO Details

Marushika Technology’s SME IPO, entirely a fresh issue of ₹26.97 crore, opens for subscription on February 12 and closes on February 16. Shares are expected to list on the NSE SME platform on February 19.

The price band is fixed at ₹111–₹117 per share, with a higher minimum investment requirement due to larger lot size.

Also Read: Best Gold Mutual Funds in India for Feb 2026!

IPO Snapshot Table

Conclusion

With two large mainboard issues and one SME IPO lined up, investors have multiple opportunities this week. Careful evaluation of valuations, business models, and risk appetite remains essential before investing.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.